The mechanism of resistance to CDK4/6 inhibition and novel combination therapy with RNR inhibition for chemo‐resistant bladder cancer

• Zhichao Tong,
• Yubo Zhao,
• Shiyu Bai,
• Benedikt Ebner,
• Lou Lienhard,
• Yuling Zhao,
• Ziqi Wang,
• Qi Pan,
• Pengyu Guo,
• Thilo Bracht,
• Barbara Sitek,
• Jürgen E. Gschwend,
• Wanhai Xu,
• Roman Nawroth

Affiliations

Zhichao Tong

Department of Urology Harbin Medical University Cancer Hospital Harbin Heilongjiang P. R. China

Yubo Zhao

Department of Urology Harbin Medical University Cancer Hospital Harbin Heilongjiang P. R. China

Shiyu Bai

NHC and CAMS Key Laboratory of Molecular Probe and Targeted Theranostics Harbin Medical University Harbin Heilongjiang P. R. China

Benedikt Ebner

Department of Urology Klinikum rechts der Isar, Technical university of Munich Munich Germany

Lou Lienhard

Department of Urology Klinikum rechts der Isar, Technical university of Munich Munich Germany

Yuling Zhao

Department of Urology Klinikum rechts der Isar, Technical university of Munich Munich Germany

Ziqi Wang

Department of Urology Harbin Medical University Cancer Hospital Harbin Heilongjiang P. R. China

Qi Pan

Department of Urology Klinikum rechts der Isar, Technical university of Munich Munich Germany

Pengyu Guo

Department of Urology Harbin Medical University Cancer Hospital Harbin Heilongjiang P. R. China

Thilo Bracht

Medizinisches Proteom‐Center, Ruhr‐Universität Bochum Bochum Germany

Barbara Sitek

Medizinisches Proteom‐Center, Ruhr‐Universität Bochum Bochum Germany

Jürgen E. Gschwend

Department of Urology Klinikum rechts der Isar, Technical university of Munich Munich Germany

Wanhai Xu

Department of Urology Harbin Medical University Cancer Hospital Harbin Heilongjiang P. R. China

Roman Nawroth

Department of Urology Klinikum rechts der Isar, Technical university of Munich Munich Germany